- Ticker
- ADVM
- Price
- 1.73
- Stock movement down
- -0.05 (-2.81%)
- Company name
- Adverum Biotechnologies Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Markedsverdi
- 172.53M
- Ent verdi
- 212.13M
- Pris/omsetning
- -
- Pris/bok
- 0.83
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- -
- Fremtidig P/E
- -
- PEG
- -
- EPS-vekst
- -
- 1 års avkastning
- 57.27%
- 3 års avkastning
- -46.98%
- 5 års avkastning
- -24.81%
- 10 års avkastning
- -
Sist oppdatert: 2023-09-08
Adverum is expecting two data readouts of Ixo-vec for the treatment of patients with Wet age-related macular degeneration in 2023. Read why ADVM is a strong buy.
23. august 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
21. august 2023
iO Charts is a Seeking Alpha partner
UTBYTTE
ADVM betaler ikke utbytte
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
11. august 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
12. juni 2023
iO Charts is a Seeking Alpha partner
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | - |
| Pris til OCF | - |
| Pris til FCF | - |
| Pris til EBITDA | - |
| EV i forhold til EBITDA | - |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | - |
| Pris til bok | 0.83 |
| EV i forhold til salg | - |
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
11. mai 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
31. mars 2023
iO Charts is a Seeking Alpha partner
ØKONOMI
Per aksje
Loading...
Per aksje-data
| Gjeldende aksje antall | 99.73M |
| EPS (TTM) | -1.57 |
| FCF per aksje (TTM) | -1.32 |
Resultatregnskap
Loading...
Resultatregnskap-data
| Inntekter (TTM) | 0.00 |
| Bruttofortjeneste (TTM) | 0.00 |
| Driftsinntekter (TTM) | -157.61M |
| Netto inntekt (TTM) | -156.21M |
| EPS (TTM) | -1.57 |
| EPS (1 år fremover) | -1.27 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | - |
| Driftsmargin (TTM) | - |
| Fortjenestemargin (TTM) | - |
Balanse
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
| Kontanter | 84.43M |
| Netto fordringer | 155.00K |
| Samlede omløpsmidler | 213.24M |
| Goodwill | 0.00 |
| Immaterielle eiendeler | 0.00 |
| Eiendom, anlegg og utstyr | 36.58M |
| Sum eiendeler | 332.36M |
| Leverandørgjeld | 846.00K |
| Kortsiktig/nåværende langsiktig gjeld | 105.70M |
| Sum kortsiktig gjeld | 28.62M |
| Sum gjeld | 124.03M |
| Aksjonærenes egenkapital | 208.34M |
| Netto varige driftsmidler | 208.34M |
Kontantstrøm
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
| Kontantstrøm fra drift (TTM) | -115.43M |
| Kapitalutgifter (TTM) | 15.98M |
| Fri kontantstrøm (TTM) | -131.41M |
| Utbetalt utbytte (TTM) | 0.00 |
Finansielle inntekter
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
| Egenkapitalavkastning | -74.98% |
| Avkastning på eiendeler | -47.00% |
| Avkastning på investert kapital | -71.14% |
| Kontantavkastning på investert kapital | -59.85% |
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
10. november 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
11. august 2022
iO Charts is a Seeking Alpha partner
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 1.77 |
| Daglig høy | 1.77 |
| Daglig lav | 1.70 |
| Daglig volum | 571K |
| Tidenes høyeste | 60.08 |
| 1 år analytikerestimat | 3.25 |
| Beta | 0.75 |
| EPS (TTM) | -1.57 |
| Utbytte per aksje | - |
| Ex-div dato | - |
| Neste dato for resultatpresentasjon | 8 Nov 2023 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| ADVM | S&P500 | |
| Nåværende prisfall fra toppnotering | -97.12% | -6.74% |
| Høyeste prisfall | -99.10% | -56.47% |
| Dato for høyeste fall | 27 Dec 2022 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -83.45% | -11.49% |
| Gj.snittlig tid til ny topp | 82 days | 13 days |
| Maks tid til ny topp | 2183 days | 1805 days |
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
7. juli 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
9. juni 2022
iO Charts is a Seeking Alpha partner
SELSKAPSOPPLYSNINGER
Markedsverdi
172.53M
Markedsverdi kategori
Small-cap
Beskrivelse
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.
Ansatte
188
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Leone D. Patterson
Land
USA
By
Redwood City
Aksjetype
Common stock
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
12. mai 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
6. april 2022
iO Charts is a Seeking Alpha partner
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Seeking AlphaPressemeldinger
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
29. mars 2022
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
7. februar 2022
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
3. januar 2022
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
4. november 2021
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
1. oktober 2021
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
1. oktober 2021
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
5. august 2021
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
23. juli 2021
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
23. juli 2021
Get the latest news and real-time alerts from Adverum Biotechnologies, Inc. (ADVM) stock at Seeking Alpha.
22. juli 2021
iO Charts is a Seeking Alpha partnerNeste side